Sign in

CIK 0001754068 · Non-accelerated filer<br>Smaller reporting company

Kalaris Therapeutics, Inc.

Sign in to watch
Ticker
KLRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
831971007
Phone
650-249-2727
Business address
400 CONNELL DRIVE, SUITE 5500, BERKELEY HEIGHTS, NJ, 07922
Former names
Allovir, Inc., ViraCyte, Inc.
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 8-K Event Acquisition or sale completed · Results of operations · Change in control · Executive or director change · Bylaws or fiscal year change · Shell status change · Regulation FD disclosure
  7. 8-K Event Executive or director change · Shareholder vote results · Other events
  8. 10-K Report Annual Report
  9. 424B3 Offering Prospectus
  10. 4 Insider Changes in Ownership
  11. 4 Insider Changes in Ownership
  12. 4 Insider Changes in Ownership
  13. 144 Insider Sale of Securities
  14. 144 Insider Sale of Securities
  15. 144 Insider Sale of Securities
  16. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  17. SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
  18. EFFECT Other Notice of Effectiveness
  19. 424B3 Offering Prospectus
  20. CORRESP Other Correspondence Between Filers and SEC Staff

Page 6 of 36 · 701 filings